Characteristic Acute-on-chronic hepatitis
B liver failure n=19
HBV-related liver
decompensated cirrhosis n=17
P value
Age (years) 48.63 ±6.62 55.41 ±11.24 0.04
Sex      
    male 18.00000 14  
    female 1.00000 3  
Blood/serum      
DNA(IU/ml) 899818.8 ±2324591.56 3350642  ±9341447.43 0.31
ALT(U/L) 98.47 ±121.59 73.29 ±99.78 0.51
AST(U/L) 130.11 ±97.06 109.65 ±163.99 0.65
TB(umol/L) 453.95 ±198.67 94.61 ±134.85 <0.01
PTA(%) 28.68 ±6.40 63.12 ±23.58 <0.01
INR 2.72 ±0.65 1.46 ±0.34 <0.01
AFP(ng/ml) 64.04 ±157.36 731.20 ±2942.51 0.36
WBC(10E9/L) 6.88 ±4.46 5.59 ±4.04 0.37
N(%) 66.55 ±13.24 61.71 ±13.27 0.28
HGB(g/L) 94.26 ±17.80 99.59 ±14.65 0.34
PLT(10E9/L) 79.84 ±39.91 120.18 ±75.37 0.06
Ascitic fluid      
WBC(10E6/L) 451 ±1450.60 4702.59 ±18870.43 0.37
N(%) 31.94 ±24.92 32.83 ±24.76 0.97
RBC(10E6/L) 12031.26 ±41396.85 6177.94 ±21639.35 0.61
GL(mmol/L) 7.54 ±2.19 8.10 ±3.31 0.55
TP(g/L) 16.42 ±11.22 12.65 ±9,73 0.29
LDH(U/L) 83.11 ±94.41 301.24 ±997.06 0.35
Aspartate transaminase (AST), alanine aminotransferase (ALT), total bilirubin (TB), prothrombin activity (PTA), international normalized ratio (INR), α-fetoprotein (AFP), platelet count (PLT), hemoglobin (HGB),  white blood cells (WBC), percentage of neutrophilic granulocyte (N), red blood cells (RBC),glucose levels (GL),total protein (TP), Lactate dehydrogenase (LDH) and Serum HBV DNA (DNA) were measured by a quantitative polymerase chain reaction assay (DaAn Diagnostics assay and Roche Amplicor, limit of detectability of 100 IU/mL; Roche Diagnostics, Basel, Switzerland) after admission.
Table 1: Characteristics of acute on chronic liver failure patients and hepatitis B virus-related liver decompensated cirrhosis patients